Elna Kochummen
Pediatric Endocrinology · Richmond, VANPI 1710147988
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.7% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $346 and has fallen 78.7% since, to $74 in 2025.
Across 71 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$189
- AbbVie$167
- Abbott$139
- Tolmar Pharmaceuticals, Inc.$82
- Tandem Diabetes Care, Inc.$76
- Lilly USA, LLC$61
- plus $598 from 20 others
What the payments were for
- Food & beverage$1,25696%
- Education$574%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 11 | $189 |
| AbbVie | 8 | $167 |
| Abbott | 6 | $139 |
| Tolmar Pharmaceuticals, Inc. | 5 | $82 |
| Tandem Diabetes Care, Inc. | 4 | $76 |
| Lilly USA, LLC | 3 | $61 |
| Arbor Pharmaceuticals, Inc. | 4 | $61 |
| Medtronic(2 entities) | 4 | $58 |
| UCB, Inc. | 3 | $56 |
| Dexcom, Inc. | 3 | $51 |
| Xeris Pharmaceuticals, Inc. | 3 | $45 |
| Tolmar, Inc. | 1 | $42 |
| Pfizer | 2 | $33 |
| Lifescan, Inc. | 2 | $33 |
| Biomarin Pharmaceutical Inc. | 1 | $26 |
| Sequel Med Tech, LLC | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Endo Pharmaceuticals Inc. | 1 | $19 |
| Endo USA, Inc. | 1 | $19 |
| Insulet Corporation | 1 | $18 |
| Rhythm Pharmaceuticals, Inc. | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
| AstraZeneca | 1 | $16 |
| Aquestive Therapeutics, Inc. | 1 | $15 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Zealand Pharma US, Inc. | 1 | $13 |
How this compares
$1,312 in reported general payments places this provider in the 65th percentile of 36 pediatric endocrinology providers in Virginia.
Other pediatric endocrinology in Richmond
- Bryce NelsonRichmond$115K
- Edmond WickhamRichmond$2K
- Anil RamaswamyRichmond$1K
- Arti ShahRichmond$415
- Ladan Davallow GhajarRichmond$241
- Mareen ThomasRichmond$185
- Ashlyn CoxRichmond$162
- Jessica RadcliffeRichmond$134
- Leslie FergusonRichmond$51
- Craig RudlinRichmond$47
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.